KR Choksey is bullish on Sun Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1827 in its research report dated March 19, 2024.
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Leave a Comment